United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 23, 2026 · Filed Jul 24, 2026

On Jul 23, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$528.58 for US$5.02M under a trading plan, leaving 324,443 shares. Filed Jul 24, 2026 (Form 4).

Sold
9,500 shares
Price
US$528.58 average (US$522.87 to US$531.83)
Value
US$5.02M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 23, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 23, 2026Common StockSale249US$522.87333,694Indirect
Jul 23, 2026Common StockSale339US$523.72333,355Indirect
Jul 23, 2026Common StockSale171US$524.86333,184Indirect
Jul 23, 2026Common StockSale387US$525.83332,797Indirect
Jul 23, 2026Common StockSale552US$526.88332,245Indirect
Jul 23, 2026Common StockSale1,989US$527.77330,256Indirect
Jul 23, 2026Common StockSale2,133US$529.08328,123Indirect
Jul 23, 2026Common StockSale2,279US$529.86325,844Indirect
Jul 23, 2026Common StockSale1,201US$530.84324,643Indirect
Jul 23, 2026Common StockSale200US$531.83324,443Indirect

Source

View original at SEC

Related